<DOC>
	<DOCNO>NCT00132639</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy preoperative docetaxel docetaxel-cisplatin combination c-stage IB/II NSCLC , select optimal preoperative therapy phase III trial .</brief_summary>
	<brief_title>Study Preoperative Docetaxel Cisplatin ( CDDP ) + Docetaxel C-stage IB-II Non-Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description>Preoperative chemotherapy substantial theoretical advantage . Several control trial way early stage ( clinical stage IB-II ) nonsmall cell lung cancer ( NSCLC ) . In trial , platinum-based doublet chemotherapy employ . Although platinum-based doublet treatment choice advance NSCLC , risk/benefit balance might well different early stage . There prospective randomized trial choose optimal preoperative chemotherapy early stage NSCLC . Comparison : Preoperative cisplatin-docetaxel combination versus docetaxel monotherapy clinical stage IB/II NSCLC .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Newly diagnose , pathologically document NSCLC Clinical stage IB ( T2N0M0 ) , IIA ( T1N1M0 ) IIB ( T2N1M0 T3N0M0 ) Ages : 1574 year old ECOG performance status 0 1 Measurable disease Ample organ function Signed informed consent Invasion first rib superior chest wall Metastasis , involvement , mediastinal node Active concomitant malignancy Unstable angina , recent myocardial infarction , heart failure Uncontrolled diabetes hypertension Pregnant lactate woman Other severe complication Systemic use corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>pulmonary neoplasm</keyword>
	<keyword>preoperative chemotherapy</keyword>
	<keyword>cisplatin , docetaxel</keyword>
	<keyword>randomize trial</keyword>
	<keyword>clinical stage IB II nonsmall cell lung cancer</keyword>
</DOC>